PDA0107 Youth perinatal HIV-associated cognitive impairment: Associations with childhood traumaPoster exhibitionA13
PDA0202 High Y-chromosome DNA concentrations are associated with increased cervical cytokine concentrations and activated cervical HIV target cell frequenciesPoster exhibitionA8
PDA0203 CyTOF analysis reveals that HIV-1 upregulates expression of multiple RNA and DNA sensors in subsets of primary CD4+ T cellsPoster exhibitionA9
PDA0205 TILRR modulates production of proinflammatory cytokines and promote leukocytes migration and may be a novel target to prevent HIV-1 vaginal infectionPoster exhibitionA5
PDA0206 Th17 cells are early targets of SIV during acute infection in rhesus macaque vaginal challenge modelPoster exhibitionA9
PDA0207 Interferon-a modulates the host glycosylation machinery during treated HIV infectionPoster exhibitionA24
PDB0102 Time to viral rebound after interruption of modern antiretroviral therapiesPoster exhibitionB40
PDB0103 Is DTG+3TC effective and safe in clinical practice? Evidence from real world dataPoster exhibitionB30
PDB0104 Comparative efficacy and safety of a combination therapy of dolutegravir and lamivudine vs 3-drug antiretroviral regimens in treatment-naïve HIV-1 infected patients at 96 weeks: A systematic review and network meta-analysisPoster exhibitionB30
PDB0105 Switching to dolutegravir plus lamivudine (DTG+3TC) is non-inferior to and as safe as continuing standard triple antiretroviral therapy (TAR)Poster exhibitionB32
seek-warrow-warrow-eseek-e11 - 20 of 2297 items